ACAT2 may be a novel predictive biomarker and therapeutic target in lung adenocarcinoma
Abstract Background Acyl‐coenzyme A cholesterol acyltransferase (ACAT) is a membrane‐binding enzyme localized in the endoplasmic reticulum. ACAT2 can promote the development of colon cancer, but its efficacy in lung adenocarcinoma (LUAD) remains uncertain. Method ACAT2 expression was performed by us...
| Published in: | Cancer Reports |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cnr2.1956 |